Scott Boyken is the founder of Outpace Bio. Outpace Bio has raised $200M in total funding. Latest round: Series A. Based in Seattle, Country.
Scott Boyken is a co-founder and Chief Technology Officer (CTO) of Outpace Bio, a Seattle-based biotech startup that utilizes artificial intelligence to develop protein designs for cancer therapies focused on solid tumors. His prior work as co-director of cell and protein engineering at Lyell Immunopharma led to the spin-out that became Outpace Bio.
Full founder directory · Investor directory · Company funding database · Fundraising library